Accelerated Dobutamine Stress Echocardiography Study
Author Information
Author(s): Minardi Giovanni, Manzara Carla, Pulignano Giovanni, Pino Paolo G, Pavaci Herribert, Sordi Martina
Primary Institution: Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy
Hypothesis
Is an accelerated dobutamine stress protocol feasible, safe, and tolerable for patients with suspected or known coronary artery disease?
Conclusion
The study demonstrates that a continuous infusion of a single high dose of dobutamine is a safe and well-tolerated method for performing stress echocardiography in patients with suspected or known coronary artery disease.
Supporting Evidence
- The mean weight-adjusted cumulative dose of dobutamine used was 330 ± 105.24 μg/kg.
- Total duration of dobutamine infusion was 6.6 ± 2.1 min.
- Heart rate rose from 69.9 ± 12.1 to 123.1 ± 22.1 beats/min at peak.
- No major side effects were observed during the test.
- The test resulted positive in 61 patients due to new or worsening wall motion abnormalities.
Takeaway
Doctors tested a new way to use dobutamine for heart stress tests, and it worked well without causing major problems.
Methodology
265 consecutive patients underwent accelerated dobutamine stress echocardiography with dobutamine administered at a constant dose of 50 μg/kg/min for up to 10 minutes.
Limitations
The study represents a single center experience and requires a larger sample size for better evaluation of uncommon side effects.
Participant Demographics
{"mean_age":63.3,"male_percentage":69.8,"hypertension_percentage":53.6,"diabetes_percentage":19.2,"dyslipidemia_percentage":43.8,"smoking_percentage":20.4}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website